Alyeska Investment Group’s Roivant Sciences ROIV Stock Holding History

Alyeska Investment Group’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.24M	Buy	+148,115	New	+$4.38M	0.01%	499
2025 Q4	–	Sell	-494,455	Closed	-$7.48M	–	713
2025 Q3	$7.48M	Buy	494,455 +378,589	+327%	+$4.69M	0.02%	418
2025 Q2	$1.31M	Buy	+115,866	New	+$1.26M	﹤0.01%	493
2024 Q4	–	Sell	-1,000,000	Closed	-$11.5M	–	649
2024 Q3	$11.5M	Hold	1,000,000	–	–	0.06%	283
2024 Q2	$10.6M	Buy	+1,000,000	New	+$11M	0.06%	263
2023 Q4	–	Sell	-282,414	Closed	-$3.3M	–	641
2023 Q3	$3.3M	Buy	+282,414	New	+$3.19M	0.02%	362
2023 Q2	–	Sell	-561,612	Closed	-$5.02M	–	617
2023 Q1	$4.14M	Buy	561,612 +392,812	+233%	+$3.23M	0.04%	316
2022 Q4	$1.35M	Buy	+168,800	New	+$939K	0.01%	341

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Alyeska Investment Group's ROIV Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Roivant Sciences (ROIV) in Q2 2026: 148,115 shares worth $5.24M. The stake represents 0.01% of the portfolio and ranks #499 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in ROIV as recently as Q3 2025.

Alyeska Investment Group first reported a position in ROIV in Q4 2022 and has held it in 8 quarters since. The position peaked at $11.5M in Q3 2024. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Alyeska Investment Group held 148,115 shares of Roivant Sciences worth $5.24M as of Q2 2026.
Roivant Sciences was a new Alyeska Investment Group position in Q2 2026.
Roivant Sciences made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #499 holding.
Alyeska Investment Group first reported a position in Roivant Sciences in Q4 2022 and has held it in 8 quarters since.
Alyeska Investment Group's Roivant Sciences position peaked at $11.5M in Q3 2024.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.